Anxiety disorders are one of the most prevalent mood disorders that can lead to impaired quality of life. Current treatment of anxiety disorders has various adverse effects, safety concerns, or restricted efficacy; therefore, novel therapeutic targets need to be studied. Sex steroid hormones (SSHs) play a crucial role in the formation of brain structures, including regions of the limbic system and prefrontal cortex during perinatal development. In the brain, SSHs have activational and organizational effects mediated by either intracellular or transmembrane G-protein coupled receptors. During perinatal developmental periods, the physiological concentrations of SSHs lead to the normal development of the brain; however, the early hormonal dysregulation could result in various anxiety diorders later in life. Sex differences in the prevalence of anxiety disorders suggest that SSHs might be implicated in their development. In this review, we discuss preclinical and clinical studies regarding the role of dysregulated SSHs signaling during early brain development that modifies the risk for anxiety disorders in a sex-specific manner in adulthood. Moreover, our aim is to summarize potential molecular mechanisms by which the SSHs may affect anxiety disorders in preclinical research. Finally, the potential effects of SSHs in the treatment of anxiety disorders are discussed.

1st Faculty of Medicine Institute of Physiology Charles University Prague Czechia

Department of Psychology University of Wisconsin Milwaukee Milwaukee WI United States

Faculty of Medicine Institute of Molecular Biomedicine Comenius University in Bratislava Bratislava Slovakia

Zobrazit více v PubMed

American Psychiatric Association.

Gater R, Tansella M, Korten A, Tiemens BG, Mavreas VG, Olatawura MO. Sex differences in the prevalence and detection of depressive and anxiety disorders in general health care settings: report from the World health organization collaborative study on psychological problems in general health care. PubMed DOI

McLean C, Asnaani A, Litz B, Hofmann S, McLean CP, Asnaani A, et al. Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness. PubMed DOI PMC

Charlson F, van Ommeren M, Flaxman A, Cornett J, Whiteford H, Saxena S. New WHO prevalence estimates of mental disorders in conflict settings: a systematic review and meta-analysis. PubMed DOI PMC

World Health Organization.

Crocco EA, Jaramillo S, Cruz-Ortiz C, Camfield K. Pharmacological management of anxiety disorders in the elderly. PubMed DOI PMC

Garakani A, Murrough JW, Freire RC, Thom RP, Larkin K, Buono FD, et al. Pharmacotherapy of anxiety disorders: current and emerging treatment options. PubMed DOI PMC

Laporte S, Chapelle C, Caillet P, Beyens M-N, Bellet F, Delavenne X, et al. Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: a meta-analysis of observational studies. PubMed DOI

Shin D, Oh YH, Eom C-S, Park SM. Use of selective serotonin reuptake inhibitors and risk of stroke: a systematic review and meta-analysis. PubMed DOI

Wu Q, Bencaz AF, Hentz JG, Crowell MD. Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case–control studies. PubMed DOI

Khanassov V, Hu J, Reeves D, van Marwijk H. Selective serotonin reuptake inhibitor and selective serotonin and norepinephrine reuptake inhibitor use and risk of fractures in adults: a systematic review and meta-analysis. PubMed DOI

Williams CL. A reevaluation of the concept of separable periods of organizational and activational actions of estrogens in development of brain and behavior. PubMed DOI

Cooke B, Hegstrom CD, Villeneuve LS, Breedlove SM. Sexual differentiation of the vertebrate brain: principles and mechanisms. PubMed DOI

McCarthy MM, De Vries GJ, Forger NG. 5.01 - Sexual differentiation of the brain: a fresh look at mode, mechanisms, and meaning. 3rd ed. In: Pfaff DW, Joëls M editors.

Schulz KM, Sisk CL. The organizing actions of adolescent gonadal steroid hormones on brain and behavioral development. PubMed DOI PMC

Vigil P, Del Río JP, Carrera B, ArÁnguiz FC, Rioseco H, Cortés ME. Influence of sex steroid hormones on the adolescent brain and behavior: an update. PubMed DOI PMC

Bakker J, De Mees C, Douhard Q, Balthazart J, Gabant P, Szpirer J, et al. Alpha-fetoprotein protects the developing female mouse brain from masculinization and defeminization by estrogens. PubMed DOI

Wallen K. Hormonal influences on sexually differentiated behavior in nonhuman primates. PubMed DOI

McCarthy MM. How it’s made: organisational effects of hormones on the developing brain. PubMed DOI PMC

Pillerová M, Borbélyová V, Hodosy J, Riljak V, Renczés E, Frick KM, et al. On the role of sex steroids in biological functions by classical and non-classical pathways. An update. PubMed DOI PMC

Hu M, Richard JE, Maliqueo M, Kokosar M, Fornes R, Benrick A, et al. Maternal testosterone exposure increases anxiety-like behavior and impacts the limbic system in the offspring. PubMed DOI PMC

Rankov Petrovic B, Hrncic D, Mladenovic D, Simic T, Suvakov S, Jovanovic D, et al. Prenatal androgenization induces anxiety-like behavior in female rats, associated with reduction of inhibitory interneurons and increased BDNF in hippocampus and cortex. PubMed DOI PMC

Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. PubMed DOI

Mendell AL, MacLusky NJ. Neurosteroid metabolites of gonadal steroid hormones in neuroprotection: implications for sex differences in neurodegenerative disease. PubMed DOI PMC

Solomon MB, Herman JP. Sex differences in psychopathology: of gonads, adrenals and mental illness. PubMed DOI PMC

Nolen-Hoeksema S, Larson J, Grayson C. Explaining the gender difference in depressive symptoms. PubMed DOI

Mir FR, Rivarola MA. Sex differences in anxiety and depression: what can (and cannot) preclinical studies tell us? DOI

Montgomery JC, Brincat M, Tapp A, Appleby L, Versi E, Fenwick PBC, et al. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. PubMed DOI

Fink G, Sumner B, Rosie R, Wilson H, McQueen J. Androgen actions on central serotonin neurotransmission: relevance for mood, mental state and memory. PubMed DOI

Frye C, Walf A, Rhodes M, Harney J. Progesterone enhances motor, anxiolytic, analgesic, and antidepressive behavior of wild-type mice, but not those deficient in type 1 5??-reductase. PubMed DOI

Walf AA, Koonce CJ, Frye CA. Estradiol or diarylpropionitrile decrease anxiety-like behavior of wildtype, but not estrogen receptor beta knockout, mice. PubMed DOI PMC

Walf AA, Frye CA. Estradiol reduces anxiety- and depression-like behavior of aged female mice. PubMed DOI PMC

Le Mellédo J-M, Baker G. Role of progesterone and other neuroactive steroids in anxiety disorders. PubMed DOI

Miller KK, Wexler TL, Zha AM, Lawson EA, Meenaghan EM, Misra M, et al. Androgen deficiency: association with increased anxiety and depression symptom severity in anorexia nervosa. PubMed

Barry JA, Hardiman PJ, Saxby BK, Kuczmierczyk A. Testosterone and mood dysfunction in women with polycystic ovarian syndrome compared to subfertile controls. PubMed DOI

Chaudhari AP, Mazumdar K, Mehta PD. Anxiety, depression, and quality of life in women with polycystic ovarian syndrome. PubMed DOI PMC

Gordon JL, Peltier A, Grummisch JA, Sykes Tottenham L. Estradiol fluctuation, sensitivity to stress, and depressive symptoms in the menopause transition: a pilot study. PubMed DOI PMC

Goldstein JM, Seidman LJ, Horton NJ, Makris N, Kennedy DN, Caviness VS, Jr, et al. Normal sexual dimorphism of the adult human brain assessed by in vivo magnetic resonance imaging. PubMed DOI

Goldman-Rakic PS, Cools AR, Srivastava K, Roberts AC, Robbins TW, Weiskrantz L. The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive. PubMed DOI

Teffer K, Semendeferi K. Chapter 9 - Human prefrontal cortex: evolution, development, and pathology. In: Hofman MA, Falk D. editors. PubMed DOI

Funahashi S, Bruce CJ, Goldman-Rakic PS. Dorsolateral prefrontal lesions and oculomotor delayed-response performance: evidence for mnemonic” scotomas”. PubMed DOI PMC

Gabrieli JDE, Poldrack RA, Desmond JE. The role of left prefrontal cortex in language and memory. PubMed DOI PMC

Miller EK, Cohen JD. An integrative theory of prefrontal cortex function. PubMed DOI

Guadagno A, Belliveau C, Mechawar N, Walker C-D. Effects of early life stress on the developing basolateral amygdala-prefrontal cortex circuit: the emerging role of local inhibition and perineuronal nets. PubMed DOI PMC

Anand KS, Dhikav V. Hippocampus in health and disease: an overview. PubMed DOI PMC

Barkus C, McHugh SB, Sprengel R, Seeburg PH, Rawlins JNP, Bannerman DM. Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion. PubMed DOI PMC

Frick KM. Molecular mechanisms underlying the memory-enhancing effects of estradiol. PubMed DOI PMC

Bannerman D, Grubb M, Deacon R, Yee B, Feldon J, Rawlins J. Ventral hippocampal lesions affect anxiety but not spatial learning. PubMed DOI

Phillips R, LeDoux J. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. PubMed DOI

Calder AJ, Lawrence AD, Young AW. Neuropsychology of fear and loathing. PubMed DOI

Feldman S, Conforti N, Weidenfeld J. Limbic pathways and hypothalamic neurotransmitters mediating adrenocortical responses to neural stimuli. PubMed DOI

Öhman A. The role of the amygdala in human fear: automatic detection of threat. PubMed DOI

Baxter MG, Croxson PL. Facing the role of the amygdala in emotional information processing. PubMed DOI PMC

Ressler KJ. Amygdala activity, fear, and anxiety: modulation by stress. PubMed DOI PMC

Derr R, Cameron S, Golden S. Pre-Analytic considerations for the proper assessment of hormones of the hypothalamic-pituitary axis in epidemiological research. PubMed DOI

Faravelli C, Lo Sauro C, Godini L, Lelli L, Benni L, Pietrini F, et al. Childhood stressful events, HPA axis and anxiety disorders. PubMed DOI PMC

Toufexis D, Rivarola MA, Lara H, Viau V. Stress and the reproductive axis. PubMed DOI PMC

Stevens JS, Hamann S. Sex differences in brain activation to emotional stimuli: a meta-analysis of neuroimaging studies. PubMed DOI

Martin EI, Ressler KJ, Binder E, Nemeroff CB. The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. PubMed DOI PMC

Shin LM, Liberzon I. The neurocircuitry of fear, stress, and anxiety disorders. PubMed DOI PMC

Pilhatsch M, Vetter NC, Hübner T, Ripke S, Müller KU, Marxen M, et al. Amygdala-Function perturbations in healthy mid-adolescents with familial liability for depression. PubMed DOI

Hare BD, Duman RS. Prefrontal cortex circuits in depression and anxiety: contribution of discrete neuronal populations and target regions. PubMed DOI PMC

Guerra-Araiza C, Coyoy-Salgado A, Camacho-Arroyo I. Sex differences in the regulation of progesterone receptor isoforms expression in the rat brain. PubMed DOI

Berg AH, Rice CD, Rahman MS, Dong J, Thomas P. Identification and characterization of membrane androgen receptors in the ZIP9 zinc transporter subfamily: I. Discovery in female atlantic croaker and evidence ZIP9 mediates testosterone-induced apoptosis of ovarian follicle cells. PubMed DOI PMC

Almey A, Milner TA, Brake WG. Estrogen receptors in the central nervous system and their implication for dopamine-dependent cognition in females. PubMed DOI PMC

American Psychiatric Association.

Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. PubMed DOI PMC

dos Santos Gonçalves J, Lopes P, Esteves F, Fernández-Berrocal P. Must we suffer to succeed?: when anxiety boosts motivation and performance. DOI

Wirtz PW, Rohrbeck CA, Burns KM. Anxiety effects on disaster precautionary behaviors: a multi-path cognitive model. PubMed DOI

Kalin NH. Novel insights into pathological anxiety and anxiety-related disorders. PubMed DOI

Chand SP, Marwaha R.

Belovicova K, Bogi E, Csatlosova K, Dubovicky M. Animal tests for anxiety-like and depression-like behavior in rats. PubMed DOI PMC

Manti M, Fornes R, Qi X, Folmerz E, Lindén Hirschberg A, de Castro Barbosa T, et al. Maternal androgen excess and obesity induce sexually dimorphic anxiety-like behavior in the offspring. PubMed DOI

Stener-Victorin E, Manti M, Fornes R, Risal S, Lu H, Benrick A. Origins and impact of psychological traits in polycystic ovary syndrome. PubMed DOI PMC

Bibel M, Barde Y. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. PubMed DOI

Berton O, McClung CA, DiLeone RJ, Krishnan V, Renthal W, Russo SJ, et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. PubMed DOI

Autry AE, Monteggia LM. Brain-derived neurotrophic factor and neuropsychiatric disorders. PubMed DOI PMC

Numakawa T, Odaka H, Adachi N. Actions of brain-derived neurotrophin factor in the neurogenesis and neuronal function, and its involvement in the pathophysiology of brain diseases. PubMed DOI PMC

Pivina SG, Akulova VK, Ordyan NÉ. Characteristics of behavior and stress reactivity of the hypophyseal-adrenocortical system in rats with prenatal inhibition of testosterone metabolism. PubMed DOI

Ordian NE, Pivina SG, Akulova VK. Effects of prenatal disturbance in the brain testosterone metabolism on anxiety level and behavior of rats in a novel environment.

Ordyan NE, Pivina SG, Akulova VK. Effects of impaired testosterone metabolism during prenatal ontogenesis on the level of anxiety and behavior of rats in a novel environment. PubMed DOI

Cheng J, Wu H, Liu H, Li H, Zhu H, Zhou Y, et al. Exposure of hyperandrogen during pregnancy causes depression- and anxiety-like behaviors, and reduced hippocampal neurogenesis in rat offspring. PubMed DOI PMC

Carbone S, Ponzo OJ, Gobetto N, Samaniego YA, Reynoso R, Scacchi P, et al. Antiandrogenic effect of perinatal exposure to the endocrine disruptor di-(2-ethylhexyl) phthalate increases anxiety-like behavior in male rats during sexual maturation. PubMed DOI

Xu X, Yang Y, Wang R, Wang Y, Ruan Q, Lu Y. Perinatal exposure to di-(2-ethylhexyl) phthalate affects anxiety- and depression-like behaviors in mice. PubMed DOI

Shono T, Suita S. Disturbed pituitary-testicular axis inhibits testicular descent in the prenatal rat. PubMed DOI

Pallarés ME, Adrover E, Baier CJ, Bourguignon NS, Monteleone MC, Brocco MA, et al. Prenatal maternal restraint stress exposure alters the reproductive hormone profile and testis development of the rat male offspring. PubMed DOI

Pallarés ME, Baier CJ, Adrover E, Monteleone MC, Brocco MA, Antonelli MC. Age-Dependent effects of prenatal stress on the corticolimbic dopaminergic system development in the rat male offspring. PubMed DOI

Rimondini R, Ågren G, Börjesson S, Sommer W, Heilig M. Persistent behavioral and autonomic supersensitivity to stress following prenatal stress exposure in rats. PubMed DOI

de Souza MA, Centenaro LA, Menegotto PR, Henriques TP, Bonini J, Achaval M, et al. Prenatal stress produces social behavior deficits and alters the number of oxytocin and vasopressin neurons in adult rats. PubMed DOI

Zuena AR, Mairesse J, Casolini P, Cinque C, Alemà GS, Morley-Fletcher S, et al. Prenatal restraint stress generates two distinct behavioral and neurochemical profiles in male and female rats. PubMed DOI PMC

Barros VG, Rodríguez P, Martijena ID, Pérez A, Molina VA, Antonelli MC. Prenatal stress and early adoption effects on benzodiazepine receptors and anxiogenic behavior in the adult rat brain. PubMed DOI

Palacios-García I, Lara-Vásquez A, Montiel JF, íaz-Véliz GFD, Sepúlveda H, Utreras E, et al. Prenatal stress down-regulates Reelin expression by methylation of its promoter and induces adult behavioral impairments in rats. PubMed DOI PMC

Akatsu S, Ishikawa C, Takemura K, Ohtani A, Shiga T. Effects of prenatal stress and neonatal handling on anxiety, spatial learning and serotonergic system of male offspring mice. PubMed DOI

Fusar-Poli L, Rodolico A, Sturiale S, Carotenuto B, Natale A, Arillotta D, et al. Second-to-fourth digit ratio (2D:4D) in psychiatric disorders: a systematic review of case-control studies. PubMed DOI PMC

Zheng Z, Cohn MJ. Developmental basis of sexually dimorphic digit ratios. PubMed DOI PMC

Lutchmaya S, Baron-Cohen S, Raggatt P, Knickmeyer R, Manning JT. 2nd to 4th digit ratios, fetal testosterone and estradiol. PubMed DOI

Manning JT, Scutt D, Wilson J, Lewis-Jones DI. The ratio of 2nd to 4th digit length: a predictor of sperm numbers and concentrations of testosterone, luteinizing hormone and oestrogen. PubMed DOI

Ventura T, Gomes MC, Pita A, Neto MT, Taylor A. Digit ratio (2D:4D) in newborns: influences of prenatal testosterone and maternal environment. PubMed DOI

Evardone M, Alexander GM. Anxiety, sex-linked behaviors, and digit ratios (2D:4D). PubMed DOI PMC

Manning JT, Bundred PE, Newton DJ, Flanagan BF. The second to fourth digit ratio and variation in the androgen receptor gene. DOI

Schneider G, Nienhaus K, Gromoll J, Heuft G, Nieschlag E, Zitzmann M. Sex hormone levels, genetic androgen receptor polymorphism, and anxiety in =50-year-old males. PubMed DOI

Rodríguez-Ramos Á, Moriana JA, García-Torres F, Ruiz-Rubio M. Emotional stability is related to 2D:4D and social desirability in women: possible implications on subjective well-being and psychopathology. PubMed DOI PMC

Risal S, Manti M, Lu H, Fornes R, Larsson H, Benrick A, et al. Prenatal androgen exposure causes a sexually dimorphic transgenerational increase in offspring susceptibility to anxiety disorders. PubMed DOI PMC

Buchholz VN, Mühle C, Kornhuber J, Lenz B, Gmel G, Mohler-Kuo M, et al. Lower Digit Ratio (2D:4D) indicative of excess prenatal androgen is associated with increased sociability and greater social capital. PubMed DOI PMC

Su Q-R, Su L-Y, Su H-R, Chen Q, Ren G-Y, Yin YOU, et al. Polymorphisms of androgen receptor gene in childhood and adolescent males with first-onset major depressive disorder and association with related symptomatology. PubMed DOI

Chen CV, Brummet JL, Lonstein JS, Jordan CL, Breedlove SM. New knockout model confirms a role for androgen receptors in regulating anxiety-like behaviors and HPA response in mice. PubMed DOI PMC

Krȩżel W, Dupont S, Krust A, Chambon P, Chapman PF. Increased anxiety and synaptic plasticity in estrogen receptor β-deficient mice. PubMed DOI PMC

ÖStlund H, Keller EVA, Hurd YL. Estrogen receptor gene expression in relation to neuropsychiatric disorders. PubMed DOI

Lund TD, Rovis T, Chung WC, Handa RJ. Novel actions of estrogen receptor-β on anxiety-related behaviors. PubMed DOI

Xu Y, Sheng H, Bao Q, Wang Y, Lu J, Ni X. NLRP3 inflammasome activation mediates estrogen deficiency-induced depression- and anxiety-like behavior and hippocampal inflammation in mice. PubMed DOI

Schüle C, Eser D, Baghai TC, Nothdurfter C, Kessler JS, Rupprecht R. Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs? PubMed DOI

Kastenberger I, Schwarzer C. GPER1 (GPR30) knockout mice display reduced anxiety and altered stress response in a sex and paradigm dependent manner. PubMed DOI PMC

Fındıklı E, Camkurt MA, Karaaslan MF, Kurutas EB, Altun H, Ýzci F, et al. Serum levels of G protein-coupled estrogen receptor 1 (GPER1) in drug-naive patients with generalized anxiety disorder. PubMed DOI

Chen B, Dowlatshahi D, MacQueen GM, Wang J-F, Young LT. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. PubMed DOI

Tian Z, Wang Y, Zhang N, Guo Y-Y, Feng B, Liu S-B, et al. Estrogen receptor GPR30 exerts anxiolytic effects by maintaining the balance between GABAergic and glutamatergic transmission in the basolateral amygdala of ovariectomized mice after stress. PubMed DOI

Hodosy J, Zelmanová D, Majzúnová M, Filová B, Malinová M, Ostatníková D, et al. The anxiolytic effect of testosterone in the rat is mediated via the androgen receptor. PubMed DOI

Edinger KL, Frye CA. Intrahippocampal administration of an androgen receptor antagonist, flutamide, can increase anxiety-like behavior in intact and DHT-replaced male rats. PubMed DOI

Zuloaga DG, Poort JE, Jordan CL, Breedlove SM. Male rats with the testicular feminization mutation of the androgen receptor display elevated anxiety-related behavior and corticosterone response to mild stress. PubMed DOI PMC

Zeidan MA, Igoe SA, Linnman C, Vitalo A, Levine JB, Klibanski A, et al. Estradiol modulates medial prefrontal cortex and amygdala activity during fear extinction in women and female rats. PubMed DOI PMC

Borrow A, Handa RJ. PubMed PMC

Imwalle DB, Gustafsson J-Å, Rissman EF. Lack of functional estrogen receptor β influences anxiety behavior and serotonin content in female mice. PubMed DOI

Walf AA, Frye CA. Administration of estrogen receptor beta-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats. PubMed DOI

Hughes ZA, Liu F, Platt BJ, Dwyer JM, Pulicicchio CM, Zhang G, et al. WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent. PubMed DOI

Wang S, Kamphuis W, Huitinga I, Zhou J, Swaab DF. Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances. PubMed DOI

Vamvakopoulos NC, Chrousos GP. Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune/inflammatory reaction. PubMed DOI PMC

Bao A-M, Swaab DF. The human hypothalamus in mood disorders: the HPA axis in the center. PubMed DOI PMC

Bao A, Fischer D, Wu Y, Hol E, Balesar R, Unmehopa U, et al. A direct androgenic involvement in the expression of human corticotropin-releasing hormone. PubMed DOI

Gomez C, Saldivar-Gonzalez A, Delgado G, Rodriguez R. Rapid anxiolytic activity of progesterone and pregnanolone in male rats. PubMed DOI

Bitran D, Shiekh M, McLeod M. Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors. PubMed DOI

Frye C, Walf A. Estrogen and/or progesterone administered systemically or to the amygdala can have anxiety-, fear-, and pain-reducing effects in ovariectomized rats. PubMed DOI

Flores RJ, Cruz B, Uribe KP, Correa VL, Arreguin MC, Carcoba LM, et al. Estradiol promotes and progesterone reduces anxiety-like behavior produced by nicotine withdrawal in female rats. PubMed DOI PMC

Reddy DS, O’Malley BW, Rogawski MA. Anxiolytic activity of progesterone in progesterone receptor knockout mice. PubMed DOI

Maron E. S68-03 new insight into role of BDNF in anxiety. DOI

Chen Z-Y, Jing D, Bath KG, Ieraci A, Khan T, Siao C-J, et al. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. PubMed DOI PMC

Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. PubMed DOI

Castrén E, Kojima M. Brain-derived neurotrophic factor in mood disorders and antidepressant treatments. PubMed DOI

Dincheva I, Yang J, Li A, Marinic T, Freilingsdorf H, Huang C, et al. Effect of early-life fluoxetine on anxiety-like behaviors in BDNF Val66Met mice. PubMed DOI PMC

Jiang X, Xu K, Hoberman J, Tian F, Marko AJ, Waheed JF, et al. BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. PubMed DOI

Frielingsdorf H, Bath KG, Soliman F, Difede J, Casey BJ, Lee FS. Variant brain-derived neurotrophic factor Val66Met endophenotypes: implications for posttraumatic stress disorder. PubMed DOI PMC

Frustaci A, Pozzi G, Gianfagna F, Manzoli L, Boccia S. Meta-analysis of the brain-derived neurotrophic factor gene (BDNF) Val66Met polymorphism in anxiety disorders and anxiety-related personality traits. PubMed DOI

Montag C, Reuter M, Newport B, Elger C, Weber B. The BDNF Val66Met polymorphism affects amygdala activity in response to emotional stimuli: evidence from a genetic imaging study. PubMed DOI

von Richthofen S, Lang UE, Hellweg R. Effects of different kinds of acute stress on nerve growth factor content in rat brain. PubMed DOI

Angelucci F, Ricci V, Gelfo F, Martinotti G, Brunetti M, Sepede G, et al. BDNF serum levels in subjects developing or not post-traumatic stress disorder after trauma exposure. PubMed DOI

Rasika S, Alvarez-Buylla A, Nottebohm F. BDNF mediates the effects of testosterone on the survival of new neurons in an adult brain. PubMed DOI

Walf AA, Frye CA. A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. PubMed DOI PMC

Morita K, Her S. Progesterone pretreatment enhances serotonin-stimulated BDNF gene expression in rat C6 glioma cells through production of 5α-reduced neurosteroids. PubMed DOI

Carrier N, Kabbaj M. Extracellular signal-regulated kinase 2 signaling in the hippocampal dentate gyrus mediates the antidepressant effects of testosterone. PubMed DOI PMC

Furuta M, Numakawa T, Chiba S, Ninomiya M, Kajiyama Y, Adachi N, et al. Estrogen, predominantly via estrogen receptor α, attenuates postpartum-induced anxiety- and depression-like behaviors in female rats. PubMed DOI

Bandelow B, Michaelis S, Wedekind D. Treatment of anxiety disorders. PubMed DOI PMC

Gambacciani M, Levancini M. Hormone replacement therapy and the prevention of postmenopausal osteoporosis. PubMed DOI PMC

Toffol E, Heikinheimo O, Partonen T. Hormone therapy and mood in perimenopausal and postmenopausal women: a narrative review. PubMed DOI

Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. PubMed DOI

Grandi G, Caroli M, Cortesi L, Toss A, Tazzioli G, Facchinetti F. Postmenopausal hormone therapy in BRCA gene mutation carriers: to whom and which? PubMed DOI

Minami CA, Freedman RA. Menopausal hormone therapy and long-term breast cancer risk: further data from the women’s health initiative trials. PubMed DOI

Weng CH, Okawa ER, Roberts MB, Park SK, Umbricht CB, Manson JE, et al. Breast cancer risk in postmenopausal women with medical history of thyroid disorder in the women’s health initiative. PubMed DOI PMC

Liu Y, Ma H, Yao J, Ralpha E. A key target for cancer therapy: a review. PubMed DOI PMC

Weiser MJ, Wu TJ, Handa RJ. Estrogen Receptor-β agonist diarylpropionitrile: biological activities of r- and s-enantiomers on behavior and hormonal response to stress. PubMed DOI PMC

Liu F, Day M, Muniz LC, Bitran D, Arias R, Revilla-Sanchez R, et al. Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory. PubMed DOI

Hanson AM, Perera KLIS, Kim J, Pandey RK, Sweeney N, Lu X, et al. A–C Estrogens as potent and selective estrogen receptor-beta agonists (SERBAs) to enhance memory consolidation under low-estrogen conditions. PubMed DOI PMC

Fleischer AW, Schalk JC, Wetzel EA, Hanson AM, Sem DS, Donaldson WA, et al. Long-term oral administration of a novel estrogen receptor beta agonist enhances memory and alleviates drug-induced vasodilation in young ovariectomized mice. PubMed DOI PMC

Freeman E, Purdy R, Coutifaris C, Rickels K, Paul SM. Anxiolytic metabolites of progesterone: correlation with mood and performance measures following oral progesterone administration to healthy female volunteers. PubMed DOI

Frye CA, Walf AA. Changes in progesterone metabolites in the hippocampus can modulate open field and forced swim test behavior of proestrous rats. PubMed DOI

Schüle C, Nothdurfter C, Rupprecht R. The role of allopregnanolone in depression and anxiety. PubMed DOI

van Wingen GA, van Broekhoven F, Verkes RJ, Petersson KM, Bäckström T, Buitelaar JK, et al. Progesterone selectively increases amygdala reactivity in women. PubMed DOI

Powell JG, Garland S, Preston K, Piszczatoski C. Brexanolone (Zulresso): finally, an FDA-approved treatment for postpartum depression. PubMed DOI

Hackett G, Cole N, Bhartia M, Kennedy D, Raju J, Wilkinson P. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes. PubMed DOI

Kim C, Barrett-Connor E, Aroda VR, Mather KJ, Christophi CA, Horton ES, et al. Testosterone and depressive symptoms among men in the Diabetes Prevention Program. PubMed DOI PMC

Cheng Y, Bateson D, Concepcion K, Stewart M, Lowy M, Sweeney S, et al. Factors associated with the initiation of testosterone replacement therapy in men from the 45 and Up Study. PubMed DOI

Zitzmann M. Testosterone, mood, behaviour and quality of life. PubMed DOI

Cornwell BR, Johnson L, Berardi L, Grillon C. Anticipation of public speaking in virtual reality reveals a relationship between trait social anxiety and startle reactivity. PubMed DOI

Hutschemaekers MHM, de Kleine RA, Davis ML, Kampman M, Smits JAJ, Roelofs K. Endogenous testosterone levels are predictive of symptom reduction with exposure therapy in social anxiety disorder. PubMed DOI

Childs E, Van Dam NT, de Wit H. Effects of acute progesterone administration upon responses to acute psychosocial stress in men. PubMed DOI PMC

Domonkos E, Hodosy J, Ostatníková D, Celec P. On the role of testosterone in anxiety-like behavior across life in experimental rodents. PubMed DOI PMC

Edinger KL, Frye CA. Testosterone’s anti-anxiety and analgesic effects may be due in part to actions of its 5alpha-reduced metabolites in the hippocampus. PubMed DOI

Carrier N, Saland SK, Duclot F, He H, Mercer R, Kabbaj M. The anxiolytic and antidepressant-like effects of testosterone and estrogen in gonadectomized male rats. PubMed DOI PMC

Maayan R, Touati-Werner D, Ram E, Strous R, Keren O, Weizman A. The protective effect of frontal cortex dehydroepiandrosterone in anxiety and depressive models in mice. PubMed DOI

Evans J, Sun Y, McGregor A, Connor B. Allopregnanolone regulates neurogenesis and depressive/anxiety-like behaviour in a social isolation rodent model of chronic stress. PubMed DOI

Wainwright S, Workman J, Tehrani A, Hamson D, Chow C, Lieblich S, et al. Testosterone has antidepressant-like efficacy and facilitates imipramine-induced neuroplasticity in male rats exposed to chronic unpredictable stress. PubMed DOI

El-Khatib YA, Sayed RH, Sallam NA, Zaki HF, Khattab MM. 17β-Estradiol augments the neuroprotective effect of agomelatine in depressive- and anxiety-like behaviors in ovariectomized rats. PubMed DOI

Shirayama Y, Fujita Y, Oda Y, Iwata M, Muneoka K, Hashimoto K. Allopregnanolone induces antidepressant-like effects through BDNF-TrkB signaling independent from AMPA receptor activation in a rat learned helplessness model of depression. PubMed DOI

Chen S, Gao L, Li X, Ye Y. Allopregnanolone in mood disorders: mechanism and therapeutic development. PubMed DOI

Akwa Y, Purdy RH, Koob GF, Britton KT. The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat. PubMed DOI

Meltzer-Brody S, Kanes SJ. Allopregnanolone in postpartum depression: role in pathophysiology and treatment. PubMed DOI PMC

Tsutsui K, Haraguchi S. Neuroprotective actions of cerebellar and pineal allopregnanolone on Purkinje cells. PubMed DOI PMC

Potmìšil P. What combinations of agomelatine with other antidepressants could be successful during the treatment of major depressive disorder or anxiety disorders in clinical practice? PubMed DOI PMC